Straits Times Index
3,111.65 +18.85 (+0.61%) S&P 500
3,911.74 +116.01 (+3.06%) Dow
31,500.68 +823.28 (+2.68%) Nasdaq
11,607.62 +375.42 (+3.34%) BTC-USD
21,379.51 +167.35 (+0.79%) CMC Crypto 200
462.12 +8.22 (+1.81%)
Abbott Laboratories (ABT)
After hours:
- Zacks
Abbott (ABT) Gains But Lags Market: What You Should Know
In the latest trading session, Abbott (ABT) closed at $106.21, marking a +0.73% move from the previous day.
- Yahoo Finance Video
FDA probes 5th infant illness tied to Abbott formula, former Nikola CEO charged with wire fraud
Notable business headlines include the FDA investigating the death of an infant who consumed formula by Abbott Laboratories, Tesla CEO Elon Musk calling his factories “gigantic money furnaces” as firestorms surround the company, and former Nikola Motors CEO Trevor Milton being charged with wire fraud.
- Motley Fool
5 Dividend Kings to Buy Now
For dividend growth investors the market drop hasn't been as severe and they can sleep better at night knowing that their passive income will almost certainly grow, regardless of what happens in the market. This is especially true for those who are invested in dividend growth stocks that have earned the title Dividend King. If you are seeking to grow your passive income and wealth over the long haul, you might want to take a closer look at any of these five Dividend Kings that look like great buys at the moment.
